Kóczián Kristóf
neuropsychiatry business leader
Kóczián Kristóf is the head of the neuropsychiatry business unit at Richter Gedeon Nyrt. and has highlighted the commercial success of cariprazine, which became one of the top-selling CNS medications globally within just a few years.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Hungary:
Kóczián Kristóf, the leader of the neuropsychiatry business unit, proudly stated that cariprazine became the 55th best-selling drug globally last year.
8